MOLECULAR PARTNERS AG Annual Research And Development Expense in CHF from 2019 to 2023

Taxonomy & unit
ifrs-full: CHF
Summary
Molecular Partners Ag annual/quarterly Research And Development Expense history and growth rate from 2019 to 2023.
  • Molecular Partners Ag Research And Development Expense for the quarter ending June 30, 2023 was ₣11.6M, a 7.47% decline year-over-year.
  • Molecular Partners Ag annual Research And Development Expense for 2023 was ₣48.8M, a 3.87% decline from 2022.
  • Molecular Partners Ag annual Research And Development Expense for 2022 was ₣50.7M, a 8.92% decline from 2021.
  • Molecular Partners Ag annual Research And Development Expense for 2021 was ₣55.7M, a 0.64% decline from 2020.
Research And Development Expense, Annual (CHF)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 48.8M -1.97M -3.87% Jan 1, 2023 Dec 31, 2023 20-F 2024-03-14
2022 50.7M -4.97M -8.92% Jan 1, 2022 Dec 31, 2022 20-F 2024-03-14
2021 55.7M -357K -0.64% Jan 1, 2021 Dec 31, 2021 20-F 2024-03-14
2020 56.1M +12.6M +28.9% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-09
2019 43.5M Jan 1, 2019 Dec 31, 2019 20-F 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.